Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised ImmuneID on the deal.ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically…
ImmuneID’s $50 Million Series A Financing


Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised ImmuneID on the deal.ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically…
…